Bruker (BRKR) Q3 2026 earnings — TrendMatrix coverage

Adjusted EPS

$0.56

Estimate

$0.42

Surprise

+34.6%

Score at report (before → after)

5.0 → 5.3/10

Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.

Bruker (BRKR) beat the $0.42 estimate with adjusted EPS of $0.56 — a large 34.6% upside surprise. TrendMatrix's engine moved from Sell (5.0/10) to Hold at 5.3/10 after the report.

• Wayfair, Lendingtree, Bruker, Zimmer Biomet And Other Big Stocks Moving Higher On Wednesday — benzinga, 2026-11-04
• Bruker Q3 2026 Earnings Call Transcript — benzinga, 2026-11-04
• Bruker Reports Third Quarter 2026 Financial Results — fiscal.ai, 2026-11-04

TrendMatrix currently rates BRKR Hold at 5.3/10.

3 of the last 4 quarters beat the estimate; this quarter's +34.6% surprise compares with a +21.8% four-quarter average.

This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.

Current price

$63.79

Stop

$59.32

Model outputs from TrendMatrix’s engine as of 2026-11-05 — shown for context, not personalized investment advice.

Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.

Industry

Medical Devices

Market cap

$9.72B

P/E (fwd)

26.5

52-week range

$32.37–$68.98

Off 52-week high

7.5%

RSI (14)

63

Volume vs avg

2.99×

Score today

5.3/10